Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

German approval for Leuprogel one-month depot product

Dec. 4, 2003

New inhibitors of ERK2 and other protein kinases covered by Vertex patent

Dec. 4, 2003

AxyS and Cytovia patent novel caspase activators for use as antitumor agents

Dec. 4, 2003

First approval for Erbitux granted by Swiss authorities

Dec. 3, 2003

FDA accepts Avastin BLA for priority review

Dec. 3, 2003

In vitro efficacy of 2-methoxyestradiol in prostate and pancreatic cancer

Dec. 3, 2003

Antiproliferative and cytotoxic effects of aplidine assessed in human cancer cell lines

Dec. 3, 2003

Preclinical and clinical antitumor efficacy and clinical safety of Bay-43-9006

Dec. 3, 2003

Radiosensitizing effects of GW-572016 and use in combination chemotherapy

Dec. 3, 2003

Antitumor effects of irofulven in advanced cancer

Dec. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...